Does drug pricing reflect innovation? The evidence suggests not – and other 2015 biotech trends
A recent Credit Suisse report entitled, “Global Biotechnology – An Outlook for 2015” is robust with data about future trends in the biotech industry. The report concludes that biotech can still outperform the general market due in part to the critical shift in large cap biotech’s business model. The industry is switching to a “Biotech 2.0″ model that’s trying to create the second generation of blockbusters to overcome losses due to the patent cliff. This CS report will help you decide if the biotech market will be bullish or bearish in 2015.
